Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
- PMID: 17142829
- DOI: 10.1093/brain/awl319
Clinical features and natural history of neuroferritinopathy caused by the FTL1 460InsA mutation
Abstract
Neuroferritinopathy is a progressive potentially treatable adult-onset movement disorder caused by mutations in the ferritin light chain gene (FTL1). Features overlap with common extrapyramidal disorders: idiopathic torsion dystonia, idiopathic Parkinson's disease and Huntington's disease, but the phenotype and natural history have not been defined. We studied a genetically homogeneous group of 41 subjects with the 460InsA mutation in FTL1, documenting the presentation, clinical course, biochemistry and neuroimaging. The mean age of onset was 39.4 years (SD = 13.3, range 13-63), beginning with chorea in 50%, focal lower limb dystonia in 42.5% and parkinsonism in 7.5%. The majority reported a family history of a movement disorder often misdiagnosed as Huntington's disease. The disease progressed relentlessly, becoming generalized over a 5-10 year period, eventually leading to aphonia, dysphagia and severe motor disability with subcortical/frontal cognitive dysfunction as a late feature. A characteristic action-specific facial dystonia was common (65%), and in 63% there was asymmetry throughout the disease course. Serum ferritin levels were low in the majority of males and post-menopausal females, but within normal limits for pre-menopausal females. MR brain imaging was abnormal on all affected individuals and one presymptomatic carrier. In conclusion, isolated parkinsonism is unusual in neuroferritinopathy, and unlike Huntington's disease, cognitive changes are absent or subtle in the early stages. Depressed serum ferritin is common and provides a useful screening test in routine practice, and gradient echo brain MRI will identify all symptomatic cases.
Comment in
-
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.Brain. 2009 Jun;132(Pt 6):e109. doi: 10.1093/brain/awn274. Epub 2008 Oct 14. Brain. 2009. PMID: 18854324 Free PMC article. No abstract available.
Similar articles
-
Spectrum of movement disorders in neuroferritinopathy.Mov Disord. 2005 Jan;20(1):95-9. doi: 10.1002/mds.20284. Mov Disord. 2005. PMID: 15390132
-
Chapter 33: the history of movement disorders.Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7. Handb Clin Neurol. 2010. PMID: 19892136 Review.
-
Neuroferritinopathy.Semin Pediatr Neurol. 2006 Sep;13(3):176-81. doi: 10.1016/j.spen.2006.08.006. Semin Pediatr Neurol. 2006. PMID: 17101456
-
[Chorea-acanthocytosis without acanthocytes].Rev Neurol (Paris). 2010 Jan;166(1):100-3. doi: 10.1016/j.neurol.2009.03.005. Epub 2009 Jun 3. Rev Neurol (Paris). 2010. PMID: 19497603 French.
-
Inherited movement disorders.Baillieres Clin Neurol. 1994 Aug;3(2):259-79. Baillieres Clin Neurol. 1994. PMID: 7952847 Review.
Cited by
-
Mutations of C19orf12, coding for a transmembrane glycine zipper containing mitochondrial protein, cause mis-localization of the protein, inability to respond to oxidative stress and increased mitochondrial Ca²⁺.Front Genet. 2015 May 19;6:185. doi: 10.3389/fgene.2015.00185. eCollection 2015. Front Genet. 2015. PMID: 26136767 Free PMC article.
-
Novel Ferritin Light Chain Gene Mutation in a Korean Patient with Neuroferritinopathy.J Mov Disord. 2019 Jan;12(1):63-65. doi: 10.14802/jmd.18062. Epub 2019 Jan 30. J Mov Disord. 2019. PMID: 30732435 Free PMC article. No abstract available.
-
Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.Brain. 2009 Jun;132(Pt 6):e109. doi: 10.1093/brain/awn274. Epub 2008 Oct 14. Brain. 2009. PMID: 18854324 Free PMC article. No abstract available.
-
The role of iron in brain ageing and neurodegenerative disorders.Lancet Neurol. 2014 Oct;13(10):1045-60. doi: 10.1016/S1474-4422(14)70117-6. Lancet Neurol. 2014. PMID: 25231526 Free PMC article. Review.
-
Neurodegeneration with brain iron accumulation: a diagnostic algorithm.Semin Pediatr Neurol. 2012 Jun;19(2):67-74. doi: 10.1016/j.spen.2012.04.001. Semin Pediatr Neurol. 2012. PMID: 22704259 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous